UNSPSC 51284115: Ceftibuten

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IW71N46B4Y. European Medicines Agency schedules Ceftibuten in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07425MIG. Ceftibuten generally arises in the molecular formula C15H14N4O6S2.

UNSPSC 51284115 Ceftibuten is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The code nominally covers a specific third-generation cephalosporin antibiotic; however, the four most recent opportunities posted under this code involve naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer pharmacy benefit program capabilities. None of these solicitations are requesting ceftibuten specifically or products in the cephalosporin family. The mismatch suggests either miscoding in the state and local procurement systems or that this code is being used as a catch-all for pharmaceutical procurement activity. State and local governments are actively buying naloxone, emergency medical supplies, generics through cooperative vehicles, and pharmacy benefit management services, but not under procurement authority aligned with a branded antibiotic Commodity code.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023. The City of Tampa issued ITB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract amount of $700,000 and a 5% small local business enterprise (SLBE) bid discount, with responses due March 13, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer pharmacy prescription programs. The Minnesota Department of Administration's Office of State Procurement, on behalf of the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed to state and local facilities across participating states including Oregon, with responses due March 26, 2026. The code shows little relevant recent activity aligned to its nominal scope.